CD40LG and congenital toxoplasmosis: In the case of neonatal diagnosis, a large-scale study conducted in 2022 [30] demonstrated that incorporating T. gondii IgA ELISA into the serological panel for congenital toxoplasmosis did not significantly enhance the overall diagnostic performance compared to IgM-based detection alone [30].